Thesis-icon2

Thesis: Syndecan-1 as a Mediator of Anti-Angiogenic Therapy-Induced Malignancy in Clear Cell Renal Cell Carcinoma

Felix Peix

Tumour Angiogenesis group

26/09/2025

12:00-

Sala Pau Viladiu

Resumen

26 de septiembre a las 12h. Sala Pau Viladiu, Hospital Duran i Reynals.
Tesis: Syndecan-1 as a Mediator of Anti-Angiogenic Therapy-Induced Malignancy in Clear Cell Renal Cell Carcinoma
Felix Peix
– Tumour Angiogenesis group

Biografía

Scroll al inicio